Patient Assistance Program

A device for 18 treatments. Complemented by a mobile application that provides a diary for the evolution of the migraine and a relaxation video.

Patient Assistance Program

Question 1 out of 1

How many migraine days do you experience per month? 

Oops! Not for you

Based on your responses, you do not meet the criteria for this program at this time

No worries—feel free to explore other option and start your journey towards a better life with minimized migraine pain

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.o eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.

Explore Other Option Retake Eligibility Test

€249,00 EUR/Per month

You are now eligible for the Program!

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed doLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do

Please Note

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

A written medical indication is required.

Skip to product information
1 of 3

The smartphone in the photo is not included.

Free shipping within Spain

Nerivio®

Nerivio®

€13.83 per treatment

18 treatments

€249,00 18 treatments

Nerivio: Drug-free migraine therapy.

Nerivio is a remote electrical neuromodulation (REN) device that offers effective migraine relief without the need for medication. It is noninvasive and has good tolerability¹².

  • One device, 18 applications
  • Session duration: 45 minutes.
  • Smartphone app included
    • Personalized therapy assessment
    • Migraine diary
    • Therapy Instruction Videos

How do I get my medical prescription in writing?

1 Tepper, SJ et.al. (2023). Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. Headache, 63(3), 377–389. https://doi.org/10.1111/head.14469


2 Yarnitsky, D., et. to the. (2019). Remote Electrical Neuromodulation (REN) Relief Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache, 59(8), 1240–1252. https://doi.org/10.1111/head.13551

program
View full details